Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of EXITIN 10 mg vs Lexapro 10 mg Under Fasting Conditions
TCTR20230208001Phase 1Unknown
- Sponsor
- Government Pharmaceutical Organization
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of escitalopram in major depressive disorder (MDD) (2 arms), sponsored by Government Pharmaceutical Organization. Status: unknown.
02
Drugs
escitalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on TCTR20230208001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230208001.